Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 2
2022 9
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean yuda kaneko (39 results)?
Antibody-mimetic drug conjugate with efficient internalization activity using anti-HER2 VHH and duocarmycin.
Sakata J, Tatsumi T, Sugiyama A, Shimizu A, Inagaki Y, Katoh H, Yamashita T, Takahashi K, Aki S, Kaneko Y, Kawamura T, Miura M, Ishii M, Osawa T, Tanaka T, Ishikawa S, Tsukagoshi M, Chansler M, Kodama T, Kanai M, Tokuyama H, Yamatsugu K. Sakata J, et al. Among authors: kaneko y. Protein Expr Purif. 2024 Feb;214:106375. doi: 10.1016/j.pep.2023.106375. Epub 2023 Oct 4. Protein Expr Purif. 2024. PMID: 37797818 Free article.
Five doses of the mRNA vaccination potentially suppress ancestral-strain stimulated SARS-CoV2-specific cellular immunity: a cohort study from the Fukushima vaccination community survey, Japan.
Tani Y, Takita M, Wakui M, Saito H, Nishiuchi T, Zhao T, Yamamoto C, Kawamura T, Sugiyama A, Nakayama A, Kaneko Y, Kodama T, Shinaha R, Tsubokura M. Tani Y, et al. Among authors: kaneko y. Front Immunol. 2023 Aug 16;14:1240425. doi: 10.3389/fimmu.2023.1240425. eCollection 2023. Front Immunol. 2023. PMID: 37662950 Free PMC article.
Association of systemic adverse reaction patterns with long-term dynamics of humoral and cellular immunity after coronavirus disease 2019 third vaccination.
Yoshida M, Kobashi Y, Kawamura T, Shimazu Y, Nishikawa Y, Omata F, Saito H, Yamamoto C, Zhao T, Takita M, Ito N, Tatsuno K, Kaneko Y, Nakayama A, Kodama T, Wakui M, Takahashi K, Tsubokura M. Yoshida M, et al. Among authors: kaneko y. Sci Rep. 2023 Jun 7;13(1):9264. doi: 10.1038/s41598-023-36429-1. Sci Rep. 2023. PMID: 37286720 Free PMC article.
Antibody mimetic drug conjugate manufactured by high-yield Escherichia coli expression and non-covalent binding system.
Yamatsugu K, Katoh H, Yamashita T, Takahashi K, Aki S, Tatsumi T, Kaneko Y, Kawamura T, Miura M, Ishii M, Ohkubo K, Osawa T, Kodama T, Ishikawa S, Kanai M, Sugiyama A. Yamatsugu K, et al. Among authors: kaneko y. Protein Expr Purif. 2022 Apr;192:106043. doi: 10.1016/j.pep.2021.106043. Epub 2021 Dec 30. Protein Expr Purif. 2022. PMID: 34973460 Free article.
Pathological complete remission of relapsed tumor by photo-activating antibody-mimetic drug conjugate treatment.
Kaneko Y, Yamatsugu K, Yamashita T, Takahashi K, Tanaka T, Aki S, Tatsumi T, Kawamura T, Miura M, Ishii M, Ohkubo K, Osawa T, Kodama T, Ishikawa S, Tsukagoshi M, Chansler M, Sugiyama A, Kanai M, Katoh H. Kaneko Y, et al. Cancer Sci. 2022 Dec;113(12):4350-4362. doi: 10.1111/cas.15565. Epub 2022 Sep 19. Cancer Sci. 2022. PMID: 36121618 Free PMC article.
Humoral immunity after second dose of BNT162b2 vaccine in Japanese communities: an observational cross-sectional study, Fukushima Vaccination Community Survey.
Kobashi Y, Kawamura T, Shimazu Y, Zhao T, Sugiyama A, Nakayama A, Kaneko Y, Nishikawa Y, Omata F, Takita M, Yamamoto C, Yoshida M, Kosaka M, Murayama A, Sugiura S, Tanaka M, Kawashima M, Uchi Y, Shindo J, Oikawa T, Shibuya K, Kodama T, Tsubokura M. Kobashi Y, et al. Among authors: kaneko y. Sci Rep. 2022 Nov 7;12(1):18929. doi: 10.1038/s41598-022-21797-x. Sci Rep. 2022. PMID: 36344597 Free PMC article.
Factors Associated with COVID-19 Vaccine Booster Hesitancy: A Retrospective Cohort Study, Fukushima Vaccination Community Survey.
Yoshida M, Kobashi Y, Kawamura T, Shimazu Y, Nishikawa Y, Omata F, Zhao T, Yamamoto C, Kaneko Y, Nakayama A, Takita M, Ito N, Kawashima M, Sugiura S, Shibuya K, Iwami S, Kim K, Iwanami S, Kodama T, Tsubokura M. Yoshida M, et al. Among authors: kaneko y. Vaccines (Basel). 2022 Mar 26;10(4):515. doi: 10.3390/vaccines10040515. Vaccines (Basel). 2022. PMID: 35455264 Free PMC article.
Antibody Profiling of Microbial Antigens in the Blood of COVID-19 mRNA Vaccine Recipients Using Microbial Protein Microarrays.
Saito H, Yoshimura H, Yoshida M, Tani Y, Kawashima M, Uchiyama T, Zhao T, Yamamoto C, Kobashi Y, Sawano T, Imoto S, Park H, Nakamura N, Iwami S, Kaneko Y, Nakayama A, Kodama T, Wakui M, Kawamura T, Tsubokura M. Saito H, et al. Among authors: kaneko y. Vaccines (Basel). 2023 Nov 7;11(11):1694. doi: 10.3390/vaccines11111694. Vaccines (Basel). 2023. PMID: 38006026 Free PMC article.
Factors associated with anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein antibody titer and neutralizing activity among healthcare workers following vaccination with the BNT162b2 vaccine.
Kobashi Y, Shimazu Y, Kawamura T, Nishikawa Y, Omata F, Kaneko Y, Kodama T, Tsubokura M. Kobashi Y, et al. Among authors: kaneko y. PLoS One. 2022 Jun 10;17(6):e0269917. doi: 10.1371/journal.pone.0269917. eCollection 2022. PLoS One. 2022. PMID: 35687563 Free PMC article.
15 results